Bell Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bell Investment Advisors's PFE Position: Q2 2026 in Review
Bell Investment Advisors reduced its Pfizer (PFE) stake by 3.7% in Q2 2026, selling an estimated $4.6K and leaving 4,641 shares worth $112K. The position accounts for 0.02% of the portfolio, ranked #174.
Bell Investment Advisors first reported a position in PFE in Q3 2021 and has held it in 19 quarters since. The position peaked at $181K in Q3 2023. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bell Investment Advisors held 4,641 shares of Pfizer worth $112K as of Q2 2026.
- Bell Investment Advisors sold 176 Pfizer shares in Q2 2026, an estimated $4.6K.
- Pfizer made up 0.02% of Bell Investment Advisors's portfolio in Q2 2026, its #174 holding.
- Bell Investment Advisors first reported a position in Pfizer in Q3 2021 and has held it in 19 quarters since.
- Bell Investment Advisors's Pfizer position peaked at $181K in Q3 2023.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.